Ivacaftor hydrate
98%
- Product Code: 101072
CAS:
1134822-07-3
| Molecular Weight: | 410.51 g./mol | Molecular Formula: | C₂₄H₃₀N₂O₄ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Ivacaftor hydrate is primarily used in the treatment of cystic fibrosis, specifically targeting the underlying cause of the disease rather than just managing symptoms. It works by enhancing the function of the CFTR protein, which is defective in individuals with certain mutations of the cystic fibrosis transmembrane conductance regulator gene. This improvement in protein function helps to regulate the flow of salt and fluids in and out of cells, leading to better hydration and clearance of mucus from the airways. As a result, patients experience improved lung function, reduced frequency of pulmonary exacerbations, and overall better quality of life. It is typically prescribed for patients with specific mutations such as G551D in the CFTR gene. Ivacaftor hydrate is often used as a long-term maintenance therapy and is sometimes combined with other cystic fibrosis treatments for enhanced efficacy.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿5,130.00 |
+
-
|
| 0.010 | 10-20 days | ฿7,695.00 |
+
-
|
Ivacaftor hydrate
Ivacaftor hydrate is primarily used in the treatment of cystic fibrosis, specifically targeting the underlying cause of the disease rather than just managing symptoms. It works by enhancing the function of the CFTR protein, which is defective in individuals with certain mutations of the cystic fibrosis transmembrane conductance regulator gene. This improvement in protein function helps to regulate the flow of salt and fluids in and out of cells, leading to better hydration and clearance of mucus from the airways. As a result, patients experience improved lung function, reduced frequency of pulmonary exacerbations, and overall better quality of life. It is typically prescribed for patients with specific mutations such as G551D in the CFTR gene. Ivacaftor hydrate is often used as a long-term maintenance therapy and is sometimes combined with other cystic fibrosis treatments for enhanced efficacy.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :